ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2015.2367 ETM-0-0-2367 Articles Therapeutic efficacy of chlorogenic acid on cadmium-induced oxidative neuropathy in a murine model HAOMAO-LIN PANNING ZHANGQING-HUA WANGXIAO-HONG Department of Neurology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250031, P.R. China Correspondence to: Dr Mao-Lin Hao, Department of Neurology, Provincial Hospital Affiliated to Shandong University. 4 Duanxing West Road, Jinan, Shandong 250031, P.R. China, E-mail: maolinhao64520@gmail.com 05 2015 17 03 2015 9 5 1887 1894 20062014 11022015 Copyright © 2015, Spandidos Publications 2015

The aim of the present study was to determine whether chlorogenic acid (CA) is able to modulate cadmium (Cd)-induced oxidative brain damage. Cd-treated rats displayed numerous pathological effects, including the inhibition of acetylcholinesterase, elevated lipid peroxidation, the depletion of enzymatic and non-enzymatic antioxidants, the reduction of membrane-bound ATPase activity, mitochondrial dysfunction and DNA fragmentation. Pretreatment of the rats with CA significantly attenuated these effects. These results lead to the hypothesis that the mechanisms by which CA attenuates the effects of Cd-induced oxidative brain damage include the maintenance of antioxidant homeostasis, inhibition of the membrane effects and the perpetuation of mitochondrial dysfunction. These data support the potential of CA as a beneficial intervention in the prevention of heavy metal poisoning due to Cd exposure.

 neurotoxicity cadmium chlorogenic acid oxidative stress Introduction

Heavy metal pollution due to cadmium (Cd), arsenic and lead is under vital scrutiny as a result of potential neurotoxicological hazards to the human population (1,2). Cd is a universal ecological toxicant frequently encountered through metal industries, in aerosolized form in cigarette smoke and in certain industrial workplaces, including those where battery manufacture and smelting take place (3). In addition to the noxious effect of Cd on vital organs such as the kidneys, liver and testes, Cd also elicits damaging effects on the central nervous system (CNS) due to a variety of factors, such as its toxicity at low concentration, extended half-life (15–30 years in humans) and low clearance rate (4). Although the blood-brain barrier (BBB) is impermeable to chronic low levels of Cd exposure, Cd may affect the permeability of the barrier and reach the brain (5). Preclinical studies have indicated that Cd induces behavioral disorders, as well as morphological and biochemical changes in the CNS (6,7). The brain region displays a high potential for oxidation and a low antioxidant defense capacity relative to the hepatic system. The neurotoxic potential of Cd has been attributed to the changes it induces in the brain enzyme network involved in counteracting oxidative stress and the disturbance of brain metabolism. Further, Cd increases the generation of free radicals, in particular superoxide ions, in the brain and hinders the antioxidant defence system, thus increasing lipid peroxidation. Moreover, free radicals generated by Cd interact with mitochondrial sites, leading to the breakdown of mitochondrial potentials, a consequence of reductions in intracellular glutathione levels (8). The mechanism by which Cd induces oxidative stress appears to be based mainly on the disruption of the prooxidant/antioxidant balance, which may lead to brain injury via oxidative damage to critical biomolecules, such as thiols, lipids, proteins and DNA (9).

Dietary polyphenols are proposed to be major antioxidants that provide health benefits due to their free radical-scavenging and metal-chelating properties, and the modulation of enzymatic activity and signal transduction pathways (10). Chlorogenic acid (CA) is a potent polyphenolic antioxidant abundantly found in apples, coffee beans, tomatoes, potatoes and apricots (11,12). CA is an ester formed between caffeic acid and quinic acid that is hydrolyzed by intestinal bacteria to various aromatic acid metabolites (13). The antioxidant potential of CA is due to the presence of vicinal hydroxyl groups on an aromatic residue, which enable it to scavenge free radicals in the aqueous phase (14) and prevent oxidative DNA damage (15). Previous studies have reported the antioxidant potential (16,17) and widespread bioactive effects of CA, such as antimutagenic, antiviral (18), anticarcinogenic (19) and tissue protection (20) effects. The neuroprotective potential of CA against oxidative insult to the brain has been well documented (21–23). The present study was carried out to investigate the neuroprotective efficacy of CA against the changes to the brain provoked by cadmium.

 Materials and methods <sec> <title>Chemicals

CA, cadmium chloride (CdCl2) and other reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA). All other chemicals were of the highest available commercial grade.

 Animals

Male Wistar rats weighing 170–200 g were obtained from the animal facility at Shandong University (Jinan, China). The animals were maintained under standard laboratory conditions of relative humidity (55±5%), temperature (25±2°C) and light (12 h light/12 h dark). They were fed standard diet pellets and water was provided ad libitum.

 Experimental design

Twenty four rats were divided into four groups (n=6 per group) and subjected to treatment as follows: Group 1: Rats received distilled water 1 ml/100 g body weight once daily by oral gavage for 30 days and served as a control group. Group 2: Rats orally received Cd as CdCl2 in saline (5 mg/kg body weight) each day for 30 days. Group 3: Rats received CA alone (60 mg/kg body weight) dissolved in distilled water, intragastric administration once daily for 30 days. Group 4: Rats orally received Cd (5 mg/kg body weight) followed by intragastric administration of CA (60 mg/kg body weight) in distilled water once daily for 30 days.

At the end of the experimental period, rats were fasted overnight and sacrificed by decapitation. Blood was collected in a heparinized BD vacutainer (BD Biosciences, Franklin Lakes, NJ, USA) and plasma samples were collected by centrifugation at 2,000 × g for 20 min. The whole brain was immediately excised and rinsed in ice-cold saline to remove the blood. The brain tissues were homogenized (25%, w/v) in 25 mmol/l phosphate buffer (pH 7.0) containing 0.25 mol/l sucrose (w/v) and centrifuged at 1,000 × g for 10 min. The clear supernatant was used for various biochemical assays to assess oxidative stress.

 Preparation of mitochondrial fraction

This was conducted as previously described (24). Brain homogenate (25%, w/v) was prepared and the supernatant was subject to centrifugation at 12,000 g for 10 min at 4°C (Remi cooling centrifuge, C-24 BL; Remi Laboratory Instruments, Mumbai, India). The mitochondrial pellets thus obtained were washed twice with phosphate buffer (pH 7.4) to remove sucrose and homogenized in phosphate buffer containing 0.5% Tween-80 (v/v). The supernatant was collected and used for enzyme analysis, then washed and resuspended in the same buffer.

 Biochemical assays Estimation of acetylcholinesterase (AChE) activity

The level of AChE in the brain homogenate was measured according to a previously described method (25) using acetylthiocholine iodide (ATCI) as a substrate. In this method, AChE in the sample hydrolyzed ATCI into thiocholine and butyric acid. The thiocholine reacted with 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) to form 5-thio-2-nitrobenzoic acid. The yellow color that developed was measured spectrophotometrically at 412 nm. The values are expressed as µmol of ATCI hydrolyzed/min/mg protein.

 Assessment of enzymatic antioxidants

The brain tissue level of superoxide dismutase (SOD) was estimated by the method of Kakkar et al (26). The reaction was based on the inhibition of the reduction of the nitro blue tetrazolium chromogen by NADH and phenazine methosulfate. One unit of SOD activity corresponds to the amount of enzyme that causes a 50% suppression of the reduction of nitro blue tetrazolium/min/mg of protein.

The catalase (CAT) activity in the brain homogenate was analyzed by the method of Sinha et al (27) wherein the breakdown of H2O2 was evaluated by measuring the UV absorption of H2O2 at 240 nm. The CAT activity is expressed as µmol H2O2 consumed/min/mg of protein.

The brain levels of glutathione peroxidase (GPx) were assayed by the method of Rotruck et al (28). The assay system was based on the reaction between a measured amount of enzyme preparation H2O2 and reduced glutathione (GSH) for a specified time period. The unreacted GSH was then measured by reaction with DTNB. The GPx activity is expressed as nmol GSH oxidized/min/mg of protein.

Glutathione S-transferase (GST) was estimated by the method of Habig et al (29). The increase in absorbance was measured at 340 nm using 1-chloro-2,4-dinitrochlorobenzene (CDNB) as substrate. GST activity is expressed in units of nmol of GSH-CDNB conjugate formed/min/mg of protein.

 Estimation of protein content

The protein content of the brain homogenate was estimated by the method of Lowry et al (30) using bovine serum albumin as a standard.

 Estimation of non-enzymatic antioxidants

The GSH levels in the brain were determined by the method of Moron et al (31). The nonprotein sulfhydryl content of cells is in the form of GSH. DTNB is a disulfide compound that is readily reduced by sulfhydryl compounds to form a highly colored yellow anion. The optical density of this yellow substance was measured at 412 nm. Results are expressed as µg/mg of protein.

The concentration of ascorbic acid (vitamin C) in the brain was determined by the method of Omaye et al (32). In this method dehydroascorbic acid, the oxidized product of ascorbic acid, reacts with 2,4-dinitrophenylhydrazine to form bis-2,4-dinitrophenylhydrazone. This undergoes further rearrangement to form a product with an absorption maximum at 520 nm. Thiourea provides the reducing medium to prevent interference from non-ascorbic acid chromogens. Results are expressed in µg/mg of protein.

Vitamin E was analyzed by the method of Desai (33). Ferric ions were reduced to ferrous ions in the presence of vitamin E, and a pink-colored complex was formed. The chelating agent orthophosphoric acid was added to minimize carotene interference in the assay. Results are expressed as µg/mg of protein.

 Measurement of tissue lipid peroxides (LPOs)

The LPO levels in the brain homogenate were measured according to the method of Ohkawa et al (34). The final colored end-product was assayed spectrophotometrically at 532 nm. The LPO level was expressed as nmol malondialdehyde (MDA)/mg protein.

 Determination of membrane-bound ATPase activities

Na+/K+-ATPase activity in the brain homogenate was assayed by the method of Bonting (35). In this method, 0.2 ml brain homogenate was added to a reaction mixture containing Tris HCl buffer (pH 7.5), 50 mM MgSO4, 50 mM KCl, 600 mM NaCl, 1 mm EDTA, 40 mM ATP and 2.5% ammonium molybdate and incubated for 15 min at 37°C. The reaction was then arrested by the addition of 1 ml ice cold 10% trichloroacetic acid. Then the amount of inorganic phosphorus (Pi) liberated in the protein-free supernatant was estimated. The activity of Mg2+-ATPase in the tissue homogenate was assayed by the method of Ohinishi (36). Brain levels of Ca2+-ATPase level were estimated as described by the method of Hjertan and Pan (37). The activities of these ATPase enzymes in tissue homogenate were expressed as µmol of Pi liberated/min/mg protein.

 Determination of mitochondrial citric acid cycle enzymes

The activity of α-ketoglutarate dehydrogenase (KDH) was estimated from the rate of reduction of NAD+ in the presence of α-KDH at 340 nm (38). The activity of isocitrate dehydrogenase (ICDH) was assayed by the method of King (39). Succinate dehydrogenase (SDH) was assayed by the method of Nulton-Persson and Szweda (40) and the activity was estimated from the rate of reduction of dichloroindophenol (DCIP) in the presence of sodium succinate at 600 nm. The levels of malate dehydrogenase (MDH) were estimated by the method of Mehler et al (41). In this reaction the rate of oxidation of NADH was measured in the presence of oxaloacetate at 340 nm.

 DNA fragmentation analysis

The DNA fragmentation pattern obtained using agarose gel electrophoresis was analyzed by the method of Watabe et al (42). Briefly, the brain samples were washed twice with phosphate-buffered saline and were lysed in a solution of 10 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.5% (w/v) sodium dodecyl sulfate and 0.1% (w/v) RNase A, with incubation for 60 min at 50°C. The lysate was then further incubated for 60 min at 50°C with 1 mg/ml proteinase K and subjected to electrophoresis on 1% agarose gel for 60 min at 50 V using 40 mM Tris acetate (pH 7.5) containing 1 mM EDTA. Subsequent to electrophoresis, DNA was visualized by staining with ethidium bromide.

 Statistical analysis

The results are expressed as mean ± standard deviation for 6 rats per group. Statistical analysis was performed by one-way analysis of variance using the SPSS software package for Windows (version 10.0; SPSS, Inc., Chicago, IL, USA. Post hoc testing was performed for inter-group comparisons using the least significance difference (LSD) test. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Effects of CA and Cd on brain AChE status

Fig. 1 displays the activity of AChE in the brains of control and experimental rats. In the present study, the levels of AChE in the brain were significantly (P<0.05) decreased in the Cd-treated rats whereas the administration of CA (60 mg/kg body weight) significantly (P<0.05) attenuated the Cd-induced reduction in AChE activity, resulting in normal AChE levels.

 Effects of CA and Cd on brain enzymatic antioxidant levels

The activities of the enzymatic antioxidants SOD, CAT, GPx and GST in the brains of control and experimental rats are displayed in Table I. Cd-treated rats displayed significant (P<0.05) reductions in the activities of SOD, CAT, GPx and GST when compared with the control rats. The intragastric administration of CA reversed the noxious effect of Cd and elicited a significant (P<0.05) restoration of the levels of antioxidant enzymes to normal values.

 Effects of CA and Cd on brain non-enzymatic antioxidant levels

Table II displays the levels of the non-enzymatic antioxidants GSH, vitamin C and vitamin E in the brains of control and experimental rats. The levels of GSH and of vitamins C and E were significantly (P<0.05) diminished in the brain tissues of Cd-treated rats when compared with control rats. Treatment with CA significantly (P<0.05) restored the depleted levels of GSH, vitamins C and E to near normal levels.

 Effects of CA and Cd on brain lipid peroxidation

Fig. 2 depicts the level of MDA, an index of lipid peroxidation, in the brains of control and experimental rats. Cd-treated rats displayed a significant (P<0.05) increase in the level of MDA in comparison with control rats. However, treatment with CA significantly (P<0.05) diminished the degree of elevation of the MDA level in the brain when compared with that in the rats treated with Cd alone.

 Effect of CA and Cd on membrane-bound ATPases

The results displayed in Table III are the changes in the activities of the ATPase enzymes Na+/K+-ATPase, Ca2+-ATPase and Mg2+-ATPase in the brains of control and experimental rats. The Cd-treated rats displayed significant (P<0.05) reductions in the activities of these ATPase enzymes on comparison with the control rats. However, treatment with CA significantly (P<0.05) increased the levels of the three ATPase enzymes in the brain when compared with those in the rats treated with Cd alone.

 Modulation of mitochondrial membrane integrity by CA and Cd

Table IV shows the activities of the citric cycle enzymes ICDH, α-KDH, SDH and MDH in the brain mitochondria of control and experimental rats. Significant reductions (P<0.05) in enzyme activities were brought about by Cd exposure in comparison with the control. However, treatment with CA restored the levels of mitochondrial enzymes to normal.

 Effects of CA and Cd on brain DNA fragmentation

Cd provoked oxidative DNA damage as demonstrated by agarose gel electrophoresis, as shown in Fig. 3. The results indicate that there was significant DNA fragmentation in the Cd-treated group compared with the control group. However, CA supplement restored the DNA integrity in comparison with that in the Cd-treated rats.

 Discussion

The brain is a highly complex tissue that regulates an array of biological metabolic events and utilizes 20% of cardiac output. However, high concentrations of peroxidizable unsaturated lipids and minimal antioxidant defence render the brain more prone to noxious oxidative stress attack than the visceral vital tissues are (43). Mounting evidence substantiates the hypothesis that oxidative stress plays a pivotal role in the etiology of neurodegenerative diseases (44,45). The neurotoxic effects of Cd are mediated through the depletion of enzymatic antioxidants and a resultant increase in lipid peroxidation (5). Further, Cd exposure elicits modulation of thiol status, alteration of ion transport and ultimately DNA damage (46).

Research substantiates that alteration of the cholinergic transmission system is a hallmark of Cd neurotoxicity (47). AChE is a key biomarker detected in order to evaluate the neurotoxicity of heavy metals. There is evidence to suggest that free radicals provoked by heavy metals are responsible for diminished AChE activity in the brain (48). In the brain, low levels of AChE could lead to noxious events such as the accumulation of acetylcholine, which causes the rapid firing of neurons leading to convulsions and status epilepticus (49). The modulation of AChE in the brain displayed by Cd is concentration dependent; at a low concentration (0.01 mM) activation of AChE occurs whilst at higher concentrations (>0.1 mM) AChE activity is inhibited (7). Further, Cd induces a conformational change in AChE that leads to the enzyme becoming unreactive (50). In the present study toxic doses (5 mg/kg) of Cd were reflected by diminished levels of AChE and treatment with CA restored the activity of AChE in the brain. The neuroprotective effects that CA elicited in the present study may be due to antioxidant and free radical-scavenging actions. Furthermore, regulation of the ionic homeostasis imbalance in neurons and the highly lipophilic nature of CA may be responsible to its neuroprotective efficacy. Studies suggest that CA has the ability to cross the BBB so that it may effectively block the deleterious effects of free radicals within the brains vascular and cellular compartments (51,52).

In the oxidative stress cascade, lipid peroxidation is the chief culprit and plays an imperative role in the toxicity of many xenobiotics (53,54). In the present study, the oxidative insult of Cd increased the MDA level, an oxidative product of LPO in brain tissue. Previous studies suggest that Cd-induced lipid peroxidation is due to the generation of hydroxyl radicals, superoxide anions, nitric oxide and H2O2 (55–57). Indeed, in the present study, treatment with CA effectively reduced the MDA level and this may be due to the ability of CA to transfer electrons, scavenge free radicals, chelate metals and activate antioxidant enzymes. GSH, the first line of defense against reactive oxygen species (ROS), is a readily available source of endogenous sulfhydryl (-SH) groups. It has been demonstrated that Cd exposure causes a marked decline in GSH levels, which may be ascribed to direct conjugation with free or protein-bound -SH groups (58). Further, GSH depletion may be due to the inhibition of glutathione reductase, the enzyme responsible for the catalytic conversion of glutathione disulfide (GSSG) to GSH (59). Cd interferes with the -SH group of metallothionein, a metal chelating protein (60) and thus reduces the GSH level. Vitamin C is a vital antioxidant that also acts as an anti-stress factor. Vitamin E, a lipophilic chain-breaking antioxidant, also plays a critical role in the detoxification of Cd. The present study exemplifies the depletion of non-enzymatic antioxidant levels in the brain, which may be due to increased utilization of these biomolecules to reduce the Cd-induced oxidative stress. CA directly acts as a scavenger to inhibit the Cd-mediated lipid peroxidation and thus reduces the utilization of non-enzymatic antioxidants, consequently leading to improvements of GSH and vitamin C and E levels in the brain. The findings observed in the present study are consistent with previous findings (22).

Cells are equipped with an array of antioxidant defence mechanisms to counteract the effects of free radicals. The present study shows that the Cd-induced increase in lipid peroxidation was accompanied by a concomitant decline in the activities of the cellular enzymatic antioxidants SOD, CAT, GPx and GST. The diminished levels of antioxidant enzymes may be due to the interaction of Cd with the -SH groups of enzymes and the decreased activity of GPx may be due to competition by Cd-metallothioneins (61). Further, a number of studies have indicated that Cd inactivates a wide array of enzymes and proteins involved in the anti-stress mechanism (62–64). In one study, the administration of CA significantly elevated the enzymatic antioxidant status in Cd-intoxicated rats, an effect that may be due to its anti-lipid peroxidative potential (65).

Membrane-bound ATPase enzymes are highly vulnerable to peroxidation and the actions of LPOs. They are bound to the plasma membrane and are involved in the translocation of sodium, potassium, calcium and magnesium ions. In the brain, the active transport of sodium and potassium mediated by Na+/K+-ATPase generates membrane potentials. In addition, Na+/K+-ATPase regulates the uptake and release of catecholamines (66,67) and serotonin (68). Ca2+-ATPase modulates intracellular calcium levels (69), and the role of Mg2+-ATPase is to maintain high brain levels of intracellular magnesium ions to control the rates of protein synthesis and cell growth (70). Thus, ATPases are vital for neuronal functions and to maintain the resting membrane potential and nerve conduction. Previous studies indicate that Cd toxicity disrupts the activities of ATPase in CNS (47,71–73), reflecting the changes to membrane and neurotransmitter functions. The reduction of ATPase activity may result from the formation of Cd-ATPase complexes through -SH groups of the enzyme and/or increased oxidative stress. Treatment with CA increased the tissue levels of ATPases, suggesting that it protects the brain by preserving its structural integrity against Cd challenge (74).

Research into cell death has focused on mitochondria due to their role as the arbiters of cell fate in response to stress. Cd is known to cause stress to the mitochondria by affecting the thiol status and depleting ATP, thereby leading to a cascade of pathophysiological events that ultimately result in necrotic cell death (75). The citric acid cycle is an essential metabolic process that is also an integral part of the oxidative defense machinery of the cells. When KDH, ICDH, SDH and MDH are inhibited, the permeability of the inner mitochondrial membrane is increased, which causes mitochondrial dysfunction, and subsequently leads to oxidative brain injury. Notably, in the present study, poisoning with Cd decreased the levels of these mitochondrial marker enzymes, whilst treatment with CA significantly attenuated these effects, possibly as a result of mitochondrial membrane stabilization (76).

Finally, in the present study Cd elevated the extent of DNA fragmentation, possibly as a result of increased ROS production during heavy metal exposure. Treatment with the CD-treated rats with CA profoundly attenuated the toxicity by diminishing the level of DNA fragmentation, possibly by inhibiting the oxidative reactive radicals induced by Cd. These results are consistent with a previous study (77).

In conclusion, the present study provides evidence for the cytoprotective potential of CA against Cd-provoked derangement of brain homeostasis. The neuroprotective effects of CA are mediated through the inhibition of lipid peroxidation and by supporting the endogenous antioxidant defense systems in brain with the subsequent restoration of AChE and membrane-bound ATPase enzyme activities, and prevention of mitochondrial dysfunction and DNA fragmentation. Recently, it was demonstrated that Cd-induced neuronal cell death involves the downregulation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and the activation of phosphoinositide 3′-kinase/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) (78). This finding may serve as a basis for future research to explore the effect of CA on the signaling mechanisms that mediate the negative effects of Cd.

 References BrenderJDSuarezLFelknerMMaternal exposure to arsenic, cadmium, lead, and mercury and neural tube defects in offspringEnviron Res101132139200610.1016/j.envres.2005.08.00316171797 JadhavSHSarkarSNPatilRDTripathiHCEffects of subchronic exposure via drinking water to a mixture of eight water contaminating metals: a biochemical and histopathological study in male ratsArch Environ Contam Toxicol53667677200710.1007/s00244-007-0031-017882470 NawrotTPlusquinMHogervorstJEnvironmental exposure to cadmium and risk of cancer: a prospective population-based studyLancet Oncol7119126200610.1016/S1470-2045(06)70545-916455475 FowlerBAMonitoring of human populations forearly markers of cadmium toxicity; a reviewToxicol Appl Pharmacol238294300200910.1016/j.taap.2009.05.00419433102 ShuklaAShuklaGSSrimalRCCadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in ratHum Exp Toxicol15400405199610.1177/0960327196015005078735464 Abu-TaweelGMAjaremJSAhmadMProtective effect of curcumin on anxiety, learning behavior, neuromuscular activities, brain neurotransmitters and oxidative stress enzymes in cadmium intoxicated miceBehav Brain Sci37484201310.4236/jbbs.2013.31008 CarageorgiouHTzotzesVPantosCMourouzisCZarrosATsakirisSIn vivo and in-vitro effects of cadmium on adult rat brain total antioxidant status, acetylcholinesterase, (Na+, K+)-ATPase and Mg2+-ATPase activities: protection by L-cysteineBasic Clin Pharmacol Toxicol94112118200410.1111/j.1742-7843.2004.pto940303.x15049340 LopezEArceCOset-GasqueMJCañadasSGonzálezMPCadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in cultureFree Radical Biol Med40940951200610.1016/j.freeradbiomed.2005.10.062 KasprzakKSOxidative DNA and protein damage in metal-induced toxicity and carcinogenesisFree Radical Biol Med32958967200210.1016/S0891-5849(02)00809-2 KasaiHFukadaSYamaizumiZSugieSMoriHAction of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis modelFood Chem Toxicol38467471200010.1016/S0278-6915(00)00014-410762733 SuzukiAYamamotoNJokuraHChlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive ratsJ Hypertens2410651073200610.1097/01.hjh.0000226196.67052.c016685206 ShibataHSakamotoYOkaMKonoYNatural antioxidant, chlorogenic acid, protects against DNA breakage caused by monochloramineBiosci Biotechnol Biochem6312951297199910.1271/bbb.63.129510478457 GonthierMPVernyMABessonCRémésyCScalbertAChlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in ratsJ Nutr13318531859200312771329 Rice-EvansCAMillerNJPagangaGStructure-antioxidant activity relationships of flavonoids and phenolic acidsFree Radical Biol Med20933956199610.1016/0891-5849(95)02227-9 ChengJCDaiFZhouBYangLLiuZLAntioxidant activity of hydroxycinnamic acid derivatives in human low density lipoprotein: mechanism and structure-activity relationshipFood Chem104132139200710.1016/j.foodchem.2006.11.012 López-GiraldoLJLaguerreMLecomteJKinetic and stoichiometry of the reaction of chlorogenic acid and its alkyl esters against the DPPH radicalJ Agric Food Chem57863870200910.1021/jf803148z19143487 SatoYItagakiSKurokawaTIn vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acidInt J Pharm403136138201110.1016/j.ijpharm.2010.09.03520933071 WangGFShiLPRenYDAnti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitroAntiviral Res83186190200910.1016/j.antiviral.2009.05.00219463857 GordonMHWishartKEffects of chlorogenic acid and bovine serum albumin on the oxidative stability of low density lipoproteins in vitroJ Agric Food Chem5858285833201010.1021/jf100106e20387813 TangYZLiuZQChemical kinetic behavior of chlorogenic acid in protecting erythrocyte and DNA against radical-induced oxidationJ Agric Food Chem561102511029200810.1021/jf802462h18983165 NakajimaYShimazawaMMishimaSHaraHWater extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actionsLife Sci80370377200710.1016/j.lfs.2006.09.01717046025 LiYShiWLiYNeuroprotective effects of chlorogenic acid against apoptosis of PC12 cells induced by methylmercuryEnviron Toxicol Pharmacol261321200810.1016/j.etap.2007.12.00821783882 VardiNParlakpinarHAtesBBeneficial effects of chlorogenic acid on methotrexate-induced cerebellar Purkinje cell damage in ratsJ Chem Neuroanat434347201210.1016/j.jchemneu.2011.09.00321946024 JohnsonDLardyHIsolation of liver or kidney mitochondriaMethods Enzymol109496196710.1016/0076-6879(67)10018-9 EllmanGLCourtneyKDAndresVJJrFeather-stoneRMA new and rapid colorimetric determination of acetylcholinesterase activityBiochem. Pharmcol78895196110.1016/0006-2952(61)90145-9 KakkarPDasBViswanathanPNA modified spectrophotometric assay of superoxide dismutaseInd J Biochem Biophys211301321984 SinhaAKColorimetric assay of catalaseAnal Biochem47389394197210.1016/0003-2697(72)90132-74556490 RotruckJTPopeALGantherHESwansonABHafemanDGHoekstraWGSelenium: biochemical role as a component of glutathione peroxidaseScience179588590197310.1126/science.179.4073.5884686466 HabigWHPabstMJJakobyWBGlutathione S-transferases. The first enzymatic step in mercapturic acid formationJ Biol Chem2497130713919744436300 LowryOHRosebroughNJFarrALRandallRJProtein measurement with the Folin phenol reagentJ Biol Chem193265275195114907713 MoronMSDepierreJWMannervikBLevels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochim Biophys Acta5826778197910.1016/0304-4165(79)90289-7760819 OmayeSTTurnbullJDSauberlichHESelected methods for the determination of ascorbic acid in animal cells, tissues and fluidsMethods Enzymol6238197910.1016/0076-6879(79)62181-X440112 DesaiIDVitamin E analysis methods for animal tissuesMethods Enzymol105138147198410.1016/S0076-6879(84)05019-96727662 OhkawaHOhishiNYagiKAssay for lipid peroxidation in animal tissues by thiobarbituric acid reactionAnal Biochem95351358197910.1016/0003-2697(79)90738-336810 BontingSLPresence of enzyme systems in mammalian tissuesMembrane and Ion TransportBilterEEWiley InterscienceLondon2572631970 OhinishiTSuzukiTSuzukiYOzawaKA comparative study of plasma membrane Mg2+ ATPase activities in normal, regenerating and malignant cellsBiochem Biophys Acta6846774198210.1016/0005-2736(82)90050-56120003 HjertanSPanHPurification and characterization of two forms of a low affinity Ca2+-ATPase from erythrocyte membranesBiochim Biophys Acta728281288198310.1016/0005-2736(83)90480-76219703 ReedLJMukherjeeBBα-ketoglutarate dehydrogenase complex from Escherichia coliMethods Enzymol1135561196910.1016/0076-6879(69)13016-5 KingJThe hydrolases - acid and alkaline phosphatasesPractical Clinical EnzymologyVan D Nostrand Co.London1992081965 Nulton-PerssonACSzwedaLIModulation of mitochondrial function by hydrogen peroxideJ Biol Chem2762335723361200110.1074/jbc.M10032020011283020 MehlerAHKornbergAGrisoliaSOchoaSThe enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvateJ Biol Chem174961977194818871256 WatabeMMasudaYNakajoSYoshidaTKuroiwaYNakayaKThe cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cellsJ Biol Chem2711406714072199610.1074/jbc.271.24.140678662906 BondySCFree-radical-mediated toxic injury to the nervous systemIn: Free Radical ToxicologyWallaceKBTaylor and FrancisOxford2212481997 EmeritJEdeasMBricaireFNeurodegenerative diseases and oxidative stressBiomed Pharmacother583946200410.1016/j.biopha.2003.11.00414739060 GandhiSAbramovAYMechanism of oxidative stress in neurodegenerationOxid Med Cell Longev2012428010201210.1155/2012/42801022685618 KumarRAgarwalAKSethPKOxidative stress-mediated neurotoxicity of cadmiumToxicol Lett896569199610.1016/S0378-4274(96)03780-08952713 AntonioMTCorredorLLeretMLStudy of the activity of several brain enzymes like markers of the neurotoxicity induced by perinatal exposure to lead and/or cadmiumToxicol Lett143331340200310.1016/S0378-4274(03)00194-212849694 TsakirisSAngelogianniPSchulpisKHStarridisJCProtective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicalsClin Biochem33103106200010.1016/S0009-9120(99)00090-910751587 OlneyJWCollinsRCSloviterRSExcitotoxic mechanisms of epileptic brain damageAdv Neurol4485787719863706027 TomlinsonGMutusBMcLennanIActivation and inactivation of acetylcholinesterase by metal ionsCan J Biochem59728735198110.1139/o81-1017317819 ChuYFBrownPHLyleBJRoasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffeesJ Agric Food Chem5798019808200910.1021/jf902095z19772322 LapchakPAThe phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activatorExp Neurol205407413200710.1016/j.expneurol.2007.02.01717439814 StohsSJBagchiDOxidative Mechanisms in the toxicity of metal ionsFree Radical Biology and Medi18321336199510.1016/0891-5849(94)00159-H AnaneRCreppyEELipid peroxidation as pathway of aluminium cytotoxicity in human skin fibroblast cultures: prevention by superoxide dismutase+catalase and vitamins E and CHum Exp Toxicol2477481200110.1191/096032701682693053 O'BrienPSalasinskiHJEvidence that the reactions of cadmium in the presence of metallothionein can produce hydroxyl radicalsArch Toxicol72690700199810.1007/s0020400505629879806 KoizumiTShirakuraGKumagaiHTatsumotoHSuzukiKTMechanism of cadmium-induced cytotoxicity in rat hepatocytes: cadmium-induced active oxygen-related permeability changes of the plasma membraneToxicology114124134199610.1016/S0300-483X(96)03477-4 TandomSKSinghSPrasadSReversal of cadmium induced oxidative stress by chelating agent, antioxidant or their combination in ratToxicol Lett145211217200310.1016/S0378-4274(03)00265-014580892 RanaSVVermaSProtective effects of GSH, vitamin E and selenium on lipid peroxidation in cadmium-fed ratsBiol Trace Elem Res51161168199610.1007/BF027854358907019 DringenRGuttererJMHirrlingerJGlutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen speciesEur J Biochem26749124916200010.1046/j.1432-1327.2000.01597.x10931173 HidalgoJAschnerMZattaPVasákMRoles of the metallothionein family of proteins in the central nervous systemBrain Res Bull15133145200110.1016/S0361-9230(01)00452-X WaisbergMJosephPHaleBBeyersmannDMolecular and cellular mechanisms of cadmium carcinogenesisToxicology19295117200310.1016/S0300-483X(03)00305-614580780 JamallISSprowlsJJEffects of cadmium and dietary selenium on cytoplasmic and mitochondrial antioxidant defense systems in the heart of rats fed high dietary copperToxicol Appl Pharmacol87102110198710.1016/0041-008X(87)90088-33798447 SarkarSYadovPBhatnagarDLipid peroxidative damage on cadmium exposure and alterations in antioxidant system in rat erythrocytes: A study with relation to timeBiometals11153157199810.1023/A:10092861303249542068 CasalinoECalzarettiGSblanoCLandriscinaCMolecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmiumToxicology1793750200210.1016/S0300-483X(02)00245-712204541 PariLKarthikesanKMenonVPComparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetesMol Cell Biochem341109117201010.1007/s11010-010-0442-520339905 BogdanskiDFTissuriABrodieBBRole of sodium, potassium, ouabain and reserpine in uptake, storage and metabolism of biogenic amines in synaptosomesLife Sci7419428196810.1016/0024-3205(68)90013-15652184 MataMFinkDJGainerHActivity-dependent energy metabolism in rat posterior pituitary, primarily reflects sodium pump activityJ Neurochem34214215198010.1111/j.1471-4159.1980.tb04643.x HernandezRBrain Na+, K+-ATPase activity possibly regulated by a specific serotonin receptorBrain Res408399402198910.1016/0006-8993(87)90414-8 SkalskaJBednarczykPPiwońskaMCalcium ions regulate K+ uptake into brain mitochondria: The evidence for a novel potassium channelInt J Mol Sci1011041120200910.3390/ijms1003110419399240 SanuiHRubinHThe role of magnesium in cell proliferation and transformationIons, Cell Proliferation and CancerBoyntonALMcKochanWLWhitfieldJPAcademic PressNew York5175371982 RajannaBHobsonMBoykinMChettyCSEffects of chronic treatment with cadmium on ATPases, uptake of catecholamines and lipid peroxidation in rat brain synaptosomesEcotoxicol Environ Saf203641199010.1016/0147-6513(90)90044-62171895 CarfagnaMAPonslerGDMuhoberacBBInhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metalsChem Biol Interact1005365199610.1016/0009-2797(95)03685-78599855 El-MissiryMAShalabyFRole of beta-carotene in ameliorating the cadmium-induced oxidative stress in rat brain and testisJ Biochem Mol Toxicol14238243200010.1002/1099-0461(2000)14:5<238::AID-JBT2>3.0.CO;2-X10969995 LeeKLeeJSJangHJChlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemiaEur J Pharmacol6898995201210.1016/j.ejphar.2012.05.02822659584 NigamDShuklaGSAgarwalAKGlutathione depletion and oxidative damage in mitochondria following exposure to cadmium in rat liver and kidneyToxicol Lett106151157199910.1016/S0378-4274(99)00059-410403659 HoLVargheseMWangJDietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in miceNutr Neurosci153745201210.1179/1476830511Y.000000002722305652 XuJGHuQPLiuYAntioxidant and DNA-protective activities of chlorogenic acid isomersJ Agric Food Chem601162511630201210.1021/jf303771s23134416 ChenSGuCXuCCelastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR networkJ Neurochem128256266201410.1111/jnc.1247424111524

Effect of Cd and CA on the level of AChE in rat brain homogenate. Values are mean ± standard deviation (n=6 per group). a*P<0.05 vs. the control group; b*P<0.05 vs. the Cd group. Cd, cadmium; CA, chlorogenic acid; AChE, acetylcholinesterase; ATCI, acetylthiocholine iodide.

Levels of MDA in the brains of experimental rats. Values are expressed as mean ± standard deviation for 6 rats in each group. a*P<0.05 compared with the control group; b* P<0.05 compared with the Cd group. Cd, cadmium; CA, chlorogenic acid; MDA, malondialdehyde.

Effect of Cd and CA on brain DNA fragmentation. Marker, DNA molecular weight marker; lane 1, control; lane 2, Cd (5 mg/kg); lane 3, CA (60 mg/kg); lane 4: Cd (5 mg/kg) + CA (60 mg/kg). Cd, cadmium; CA, chlorogenic acid.

Effects of CD and CA on the activities of enzymatic antioxidants in the brain.

Groups SOD (U/mg protein) CAT (U/mg protein) GPx (nmol/min/mg protein) GST (nmol/min/mg protein)
Control 7.22±0.19 4.35±0.1 2.87±0.13 5.59±0.45
Cd (5 mg/kg) 4.11±0.13a 1.56±0.07a 1.38±0.06a 3.18±0.21a
CA (60 mg/kg) 7.91±0.17a,b 3.70±0.08a,b 3.95±0.18a,b 4.62±0.17b
Cd (5 mg/kg) + CA (60 mg/kg) 7.10±0.09b 4.20±0.14b 4.10±0.15a,b 5.43±0.10b

Values are expressed as mean ± standard deviation for 6 rats in each group.

P<0.05 compared with the control group

P<0.05 compared with the Cd group. Units of measurement are: for SOD, U/mg protein where 1 unit is equal to the amount of enzyme that causes a 50% suppression of the reduction of nitro blue tetrazolium/min/mg of protein; for CAT, U/mg protein where 1 unit corresponds to 1 nmol H2 consumed/min/mg protein; for GPx, nmol GSH oxidized/min/mg protein; and for GST, nmol GSH-CDNB conjugate formed/min/mg protein. Cd, cadmium; CA, chlorogenic acid; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GST, glutathione S-transferase; GSH, reduced glutathione; CDNB, 1-chloro-2,4-dinitrochlorobenzene.

Effect of Cd and CA on the levels of non-enzymatic antioxidants (µg/mg protein).

Groups GSH Vitamin C Vitamin E
Control 5.82±0.48 2.7±0.19 2.8±0.24
Cd (5 mg/kg) 2.16±0.29a 1.2±0.07a 1.6±0.18a
CA (60 mg/kg) 5.64±0.35b 2.6±0.12 2.9±0.31
Cd (5 mg/kg) + CA (60 mg/kg) 6.12±0.51b 2.1±0.12b 2.3±0.21b

Values are expressed as mean ± standard deviation for 6 rats in each group.

P<0.05 compared with the control group

P<0.05 compared with the Cd group. Cd, cadmium; CA, chlorogenic acid; GSH, reduced glutathione.

Effect of Cd and CA on the levels of brain membrane ATPases (µmol phosphorus/min/mg protein).

Groups Na+/K+-ATPase Mg2+-ATPase Ca2+-ATPase
Control 2.27±0.06 1.18±0.05 1.23±0.07
Cd (5 mg/kg) 1.18±0.05a 0.38±0.07a 0.53±0.07a
CA (60 mg/kg) 2.21±0.04 1.07±0.05 1.11±0.05
Cd (5 mg/kg) + CA (60 mg/kg) 2.15±0.04b 0.80±0.11b 0.90±0.07b

Values are expressed as mean ± standard deviation for 6 rats in each group.

P<0.05 compared with the control group

P<0.05 compared with the Cd group. Cd, cadmium; CA, chlorogenic acid.

Effect of Cd and CA on the activities of brain mitochondrial citric acid cycle enzymes.

Groups SDH MDH α-KDH ICDH
Control 43.57±2.35 875.85±32.65 54.27±3.97 155.57±3.88
Cd (5 mg/kg) 12.65±4.55a 553.43±26.38a 23.43±1.83a 99.41±6.25a
CA (60 mg/kg) 43.94±1.47 870.05±31.41 52.84±2.73 160.64±5.58
Cd (5 mg/kg) + CA (60 mg/kg) 26.25±1.35b 711.59±26.26b 38.46±1.52b 134.02±3.57b

Units of measurement are: for SDH, nmol succinate oxidized/min/mg protein; for MDH, nmol NADH oxidized/min/mg protein; for KDH, nmol ferricyanide formed/h/mg protein; and for ICDH, nmol α-ketoglutarate formed/h/mg protein. Values are expressed as mean ± standard deviation for 6 rats in each group.

P<0.05 compared with the control group

P<0.05 compared with the Cd group. CD, cadmium; CA, chlorogenic acid; SDH, succinate dehydrogenase; MDH, malate dehydrogenase; α-KDH, α-ketoglutarate dehydrogenase; ICDH, isocitrate dehydrogenase.